↓ Skip to main content

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults…

Overview of attention for article published in Respiratory Research, October 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Readers on

mendeley
94 Mendeley
Title
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma
Published in
Respiratory Research, October 2020
DOI 10.1186/s12931-020-01503-z
Pubmed ID
Authors

Michael E. Wechsler, Gene Colice, Janet M. Griffiths, Gun Almqvist, Tor Skärby, Teresa Piechowiak, Primal Kaur, Karin Bowen, Åsa Hellqvist, May Mo, Esther Garcia Gil

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Other 13 14%
Researcher 13 14%
Student > Master 7 7%
Student > Bachelor 6 6%
Student > Ph. D. Student 4 4%
Other 14 15%
Unknown 37 39%
Readers by discipline Count As %
Medicine and Dentistry 28 30%
Nursing and Health Professions 11 12%
Biochemistry, Genetics and Molecular Biology 5 5%
Social Sciences 4 4%
Immunology and Microbiology 2 2%
Other 5 5%
Unknown 39 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2023.
All research outputs
#8,269,042
of 25,998,826 outputs
Outputs from Respiratory Research
#1,092
of 3,107 outputs
Outputs of similar age
#169,865
of 439,454 outputs
Outputs of similar age from Respiratory Research
#26
of 92 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,107 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,454 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.